BioSpace News Archive

Amgen (NASDAQ:AMGN) will present at Morgan Stanley’s 2022 Global Healthcare Conference at 9:10 a.m. ET on Tuesday, Sept. 13, 2022.

Dynavax Technologies Corporation (Nasdaq: DVAX), today announced that Ryan Spencer, Chief Executive Officer, will participate in a virtual fireside chat at the H.C. Wainwright 24th Annual Global Investment Conference, being held September 12-14, 2022.

Champions Oncology, Inc. announced its financial results for its first quarter of fiscal 2023, ended July 31, 2022.

Pipeline Therapeutics, a clinical-stage biopharmaceutical company pioneering precision neuroregeneration, announced today that company management will participate virtually in the UBS Biotechnology Private Company Symposium, being held September 21-22, 2022.

InnoCare Pharma (HKEX: 09969) announced today that the first patient was dosed in the phase II registrational trial (Registry number: CTR20221519) of tafasitamab in combination with lenalidomide for adult patients in China who have relapsed or refractory diffuse large B-cell lymphoma (DLBCL) and are not eligible for autologous stem cell transplantation (ASCT).

Sapphiros has completed the acquisition of Flexotronix Limited.

GRAIL, LLC, a healthcare company whose mission is to detect cancer early when it can be cured, today announced final results from the interventional PATHFINDER study will be presented at the European Society for Medical Oncology (ESMO) Congress 2022 in Paris.

Seres Therapeutics, Inc., a leading microbiome therapeutics company, announced that Matthew Henn, Ph.D., Chief Scientific Officer at Seres, will be presenting at the World Anti-Microbial Resistance Congress being held on September 7-8, 2022 in National Harbor, Maryland.

Innoviva, Inc. announced that Pavel Raifeld, Chief Executive Officer, will participate in a fireside chat at the Morgan Stanley 20th Annual Global Healthcare Conference on Wednesday, September 14th at 11:10 a.m. Eastern Time.

PureTech Health plc announced that Daphne Zohar, Founder and Chief Executive Officer, and Julie Krop, M.D., Chief Medical Officer, will participate in a fireside chat at the Morgan Stanley Global Healthcare Conference in New York City on Wednesday, September 14, 2022, at 2:05pm EDT.